Nanotechnology-based strategies for combating coronavirus


Ayan S., Arancı K., ARI YUKA S., PELİT ARAYICI P., ÜSTÜNDAĞ C. B.

Nanotechnology and Antivirus Nanomaterials for Combating COVID-19: Strategies against SARS-CoV-2 Variants in the Post-pandemic Era, Elsevier, ss.121-158, 2025

  • Yayın Türü: Kitapta Bölüm / Araştırma Kitabı
  • Basım Tarihi: 2025
  • Doi Numarası: 10.1016/b978-0-443-33002-5.00004-x
  • Yayınevi: Elsevier
  • Sayfa Sayıları: ss.121-158
  • Anahtar Kelimeler: COVID-19, nanotechnology, SARS-CoV-2, drug, drug development, Infectious disease, pharmaceutics, virology
  • Yıldız Teknik Üniversitesi Adresli: Evet

Özet

There have been many diseases since the beginning of life. Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be transmitted from human to human via three different ways as aerosol, direct contact, and droplet. In this chapter, first, the structure of SARS-CoV-2 and its variants is explained. After that, nanotechnological approaches based on protection, diagnosis, and treatment strategies for COVID-19 are considered. Although developing vaccines and drugs is a tiring and expensive process that takes more than a decade, this process has enabled significant developments against COVID-19 within a few months, thanks to the rapid advancement of technology day by day. In this chapter, the limitations and challenges of nanotechnology in the process and novel future studies for COVID-19 are examined.